TAUSHA RHOADES: Open Payments
NPI 1134691512 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 24 payments from 12 companies in 2025. Trend: 2023 $638 · 2024 $515 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $214 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| ABBVIE INC. | 2 | $41 |
| PFIZER INC. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Abbott Laboratories | 1 | $19 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $18 |
Products named: Ozempic, Wegovy, NURTEC ODT, REXULTI, FARXIGA, Auvelity, MOUNJARO, QULIPTA.
Industry payments across GA — which companies pay providers there.
